Allan-Herndon-Dudley Syndrome
- PMID: 40131620
- DOI: 10.1007/s12098-025-05507-9
Allan-Herndon-Dudley Syndrome
Abstract
X-linked MCT 8 mutations cause Allan-Herndon-Dudley syndrome (AHDS), characterized by severe developmental delay and specific thyroid function abnormality. The report describes a 2-y-old boy who presented with severe developmental delay, generalized hypotonia and thyroid function abnormality (high FT3, low FT4 and normal TSH) suggesting a form of impaired thyroid hormone sensitivity. Whole exome sequencing (WES) analysis revealed mutation in exon 3 of MCT 8 gene. Improvement of neurodevelopmental delay and clinical and biochemical features of thyrotoxicosis occurs with use of tri iodoacetic acid.
Keywords: Developmental Delay; Emcitate; MCT8; Tiratricol.
© 2025. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.
Conflict of interest statement
Declarations. Conflict of Interest: None.
References
-
- Kulkarni A, Desai DR, Kothari PN. Allan-Herndon-Dudley syndrome: report of a novel pathogenic variant in MCT8 gene. J Pediatr Endocrinol Diabetes. 2022;2:78–80. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources